NCT00616863View on ClinicalTrials.gov

Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
EpilepsySeizures
Interventions
DRUG

Oxcarbazepine

Trial Locations (1)

H4R 2N6

MDS Pharma Services, Montreal

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00616863 - Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter